| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $64.6M | -55.7% |
| SG&A Expense | $53.2M | -39.4% |
| Operating Income | -$121.3M | -12.3% |
| Interest Expense | $0 | -100.0% |
| Income Tax | $0 | — |
| Net Income | $136K | +100.1% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.8M | -75.9% |
| Current Assets | $38.7M | -78.0% |
| Total Assets | $139.8M | -61.0% |
| Current Liabilities | $41.2M | -58.2% |
| Total Liabilities | $126.0M | -68.8% |
| Stockholders' Equity | $13.8M | +130.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$148.6M | -26.6% |
| Capital Expenditures | $380K | -95.2% |
| Investing Cash Flow | $142.3M | +1244.7% |
| Financing Cash Flow | -$90.4M | -226.0% |
| Free Cash Flow | -$149.0M | -18.9% |